Back to Agenda
LS14: Global Oncology Development - Aiming to Be A Game Changer
Session Chair(s)
Hironobu Saito, PHD
Corporate Advisor, Daiichi Sankyo Co., Ltd., Japan
Speaker(s)
Kenta Kachi
Vice President, 3H Clinical Trial Inc., Japan
Have an account?